1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1358/dot.2007.43.2.1032058" target="_blank" rel="noreferrer noopener">http://doi.org/10.1358/dot.2007.43.2.1032058</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
77-83
Issue
2
Volume
43
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Travoprost 0.004%/timolol 0.5% fixed combination
Publisher
An entity responsible for making the resource available
Drugs of Today
Date
A point or period of time associated with an event in the lifecycle of the resource
2007
2007-02
Subject
The topic of the resource
efficacy; Intraocular pressure; latanoprost; ocular hypertension; open-angle glaucoma; ophthalmic solution; Pharmacology & Pharmacy; preservatives; safety; therapy; timolol
Creator
An entity primarily responsible for making the resource
Noecker R J; Awadallah N S; Kahook M Y
Description
An account of the resource
Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrated the efficacy and safety of this medication used once daily for the treatment of open-angle glaucoma and ocular hypertension. This fixed combination has been compared to travoprost and timolol used concomitantly, latanoprost and timolol used concomitantly, latanoprost/timolol fixed combination and travoprost and timolol monotherapy. Fixed-combination medicines such as travoprost/timolol offer the potential of maximizing patient adherence by decreasing the burden of using multiple topical agents that lower intraocular pressure, and by potentially decreasing the overall cost to both the patient and the health-care system. We discuss the benefits of fixed-dose medications, report on previous clinical trials and summarize the existing data on the performance of travoprost/timolol. (c) 2007 Prous Science. All rights reserved.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1358/dot.2007.43.2.1032058" target="_blank" rel="noreferrer noopener">10.1358/dot.2007.43.2.1032058</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
2007
Awadallah N S
Department of Family & Community Medicine
Drugs of Today
efficacy
Intraocular Pressure
Journal Article
Kahook M Y
latanoprost
NEOMED College of Medicine
Noecker R J
Ocular Hypertension
open-angle glaucoma
ophthalmic solution
Pharmacology & Pharmacy
Preservatives
Safety
therapy
timolol